rivastigmine mylan 4,5 mg kapsułki twarde
viatris ltd - rivastigmini hydrogenotartras - kapsułki twarde - 4,5 mg
aprepitant mylan 125 mg kapsułki twarde
mylan ireland limited - aprepitantum - kapsułki twarde - 125 mg
aprepitant mylan 80 mg kapsułki twarde
mylan ireland limited - aprepitantum - kapsułki twarde - 80 mg
acopair 18 μg proszek do inhalacji w kapsułce twardej
viatris limited - tiotropium - proszek do inhalacji w kapsułce twardej - 18 μg
clindamycin mylan 300 mg kapsułki twarde
viatris ltd - clindamycinum - kapsułki twarde - 300 mg
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - besylan klopidogrelu - peripheral vascular diseases; stroke; myocardial infarction - Środki przeciwzakrzepowe - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). elewacja segmentu st ostry zawał mięśnia sercowego, w połączeniu z asa w leczenie pacjentów kwalifikujących się do leczenia trombolitycznego. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. aby uzyskać więcej informacji, proszę odnieść się do rozdziału 5.
dasatinib viatris 20 mg tabletki powlekane
viatris ltd - dasatinibum - tabletki powlekane - 20 mg
dasatinib viatris 50 mg tabletki powlekane
viatris ltd - dasatinibum - tabletki powlekane - 50 mg
dasatinib viatris 70 mg tabletki powlekane
viatris ltd - dasatinibum - tabletki powlekane - 70 mg
dasatinib viatris 80 mg tabletki powlekane
viatris ltd - dasatinibum - tabletki powlekane - 80 mg